Therapy News and Research

RSS

Early menopause increases risk of metabolic syndrome in women

The prevalence of metabolic syndrome, a dangerous and potentially deadly condition, increases with menopause.

21 Oct 2025

Researchers develop a novel approach to monitor CD8⁺ T cell activity over time

The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key to the success of modern day cancer immunotherapies.

21 Oct 2025

New discovery could someday help prevent breast cancer recurrence

Know someone who's been diagnosed with breast cancer? There's a good chance that person has received hormone therapy.

21 Oct 2025

Leveraging the microbiome to promote healthy living and aging

From probiotic pills to skincare products to dedicated meal plans, the microbiome is all the rage in the health and wellness space.

21 Oct 2025

New AI-driven approach identifies treatments to reprogram and destroy cancer stem cells

Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells – hard-to-find cells that help cancers spread, come back after treatment and resist therapy.

21 Oct 2025

Botulinum toxin injections could be a powerful tool for treating post-amputation pain

Botulinum toxin injections provided greater short-term relief for phantom limb pain than standard medical and surgical care among Ukrainian war amputees, reports a new study led by Northwestern Medicine and Ukrainian physicians.

21 Oct 2025

Earlier menopause and reduced cardiac function may negatively affect brain health

Women face a higher risk of developing both cardiovascular disease and Alzheimer's disease than men. Cardiovascular disease is linked to an increased likelihood of Alzheimer's disease, especially among women.

21 Oct 2025

Researchers develop a new approach for treating children with neuroblastoma

A research team from the University of Zurich and the University Children's Hospital Zurich has developed a new approach for treating children with malignant tumors of the nervous system.

21 Oct 2025

Study provides a new approach for the treatment of prostate tumors

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer.

21 Oct 2025

New virtual reality training task can help stroke survivors living with visuospatial neglect

A team of researchers at the University of Jyväskylä (JYU) has developed and tested a new virtual reality (VR) training task designed to help stroke survivors living with visuospatial neglect (VSN), a disabling condition that affects attention and awareness of one side of space.

21 Oct 2025

BMAC treatment accelerates healing for ACL, MCL, and meniscus tears

Bone marrow aspirate concentrate (BMAC) is a common treatment for joint injuries.

21 Oct 2025

Tailored deep brain stimulation offers new hope for hard-to-treat epilepsy

Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don't respond to medication and aren't candidates for surgery. Their approach, published today in Nature Communications, uses deep brain stimulation (DBS) that is tailored to each patient's unique brain wiring.

21 Oct 2025

AGA updates guidelines for Barrett's Esophagus to catch cancer early

The American Gastroenterological Association (AGA) released a new clinical practice guideline on the surveillance of Barrett's esophagus, the only known precursor to esophageal cancer (adenocarcinoma), a highly lethal cancer whose incidence has risen substantially over recent decades.

21 Oct 2025

Study suggests earlier start of hormone therapy optimizes long-term health outcomes

Menopause may take a toll on women physically and emotionally due to declining estrogen levels. For some, the use of hormone therapy has proven valuable in managing bothersome menopause symptoms.

21 Oct 2025

Transdermal hormone therapy offers potential reduction in anxiety and depression

Hormone therapy–oral and transdermal–remains the most effective treatment for such bothersome menopause symptoms as hot flashes and is generally considered safe for most patients. A new study shows that risk profiles are different based on how the hormones are administered.

21 Oct 2025

Study reveals differing prescribing patterns for menopause therapy

Not all healthcare professionals receive the same type of formal education. That may help explain the results of a new study which suggests that provider type and specialty greatly affect whether a woman receives prescription medication treatment for menopause-related care and, if so, what kind of treatment she receives.

21 Oct 2025

Hormone therapy does not consistently reduce menopause-related anxiety, new review finds

Anxiety is a common and significant symptom of menopause and perimenopause, largely due to hormone fluctuations. Numerous studies have focused on the potential benefits of hormone therapy in reducing anxiety.

21 Oct 2025

Largest trial of adjuvant pembrolizumab in Merkel cell carcinoma reports key benefit

A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's immune system to target and eliminate cancer cells appeared to reduce the risk of distant metastases for an aggressive form of skin cancer when given immediately after surgery, but did not significantly reduce the overall risk of recurrence, which was a co-primary endpoint of the trial.

21 Oct 2025

Gender-affirming hormone therapy rewrites body proteins to match gender identity

Melbourne researchers have discovered gender-affirming hormone therapy can alter body proteins to match a person's gender identity, potentially affecting susceptibility to certain health conditions.

21 Oct 2025

Novel combination therapy shows promise for advanced neuroendocrine tumors

A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for patients with advanced neuroendocrine tumors, according to new clinical trial data presented this week at the European Society for Medical Oncology (ESMO) Congress 2025.

21 Oct 2025

Therapy News and Research

Early menopause increases risk of metabolic syndrome in women

Researchers develop a novel approach to monitor CD8⁺ T cell activity over time

New discovery could someday help prevent breast cancer recurrence

Leveraging the microbiome to promote healthy living and aging

New AI-driven approach identifies treatments to reprogram and destroy cancer stem cells

Botulinum toxin injections could be a powerful tool for treating post-amputation pain

Earlier menopause and reduced cardiac function may negatively affect brain health

Researchers develop a new approach for treating children with neuroblastoma

Study provides a new approach for the treatment of prostate tumors

New virtual reality training task can help stroke survivors living with visuospatial neglect

BMAC treatment accelerates healing for ACL, MCL, and meniscus tears

Tailored deep brain stimulation offers new hope for hard-to-treat epilepsy

AGA updates guidelines for Barrett's Esophagus to catch cancer early

Study suggests earlier start of hormone therapy optimizes long-term health outcomes

Transdermal hormone therapy offers potential reduction in anxiety and depression

Study reveals differing prescribing patterns for menopause therapy

Hormone therapy does not consistently reduce menopause-related anxiety, new review finds

Largest trial of adjuvant pembrolizumab in Merkel cell carcinoma reports key benefit

Gender-affirming hormone therapy rewrites body proteins to match gender identity

Novel combination therapy shows promise for advanced neuroendocrine tumors

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News